USPTO serial 79390158
M
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 11, 2025
- Examiner
- SIMCOX, KYLE DUNCAN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with M?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Robert S. Broder
Robert S. Broder Collard & Roe, P.C.1077 Northern Blvd.Roslyn, NY 11576United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biochemical and biotechnological products for industrial and scientific purposes, namely biochemicals and chemicals for use in biotechnological manufacturing processes for industrial and scientific purposes; chemicals used in industry and science; biochemicals, chemical and biotechnological products, namely, nucleotides, polynucleotides, enzymes and monoclonal antibodies for scientific in vitro and in vivo applications; biochemicals, chemical and biotechnological preparations, namely, precursors for in vitro genetic engineering use; biochemical and biotechnological preparations, namely, monoclonal antibodies for in vitro scientific or research use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; chemical and biochemical products for research purposes, for laboratory use and for industrial purposes; chemical reagents for use in the field of molecular biology, other than for medical or veterinary use; chemical stabilizers in the nature of enzyme stabilizers for use on biological samples; reagents for the stabilization of biological samples for research purposes; chemical reagents for molecular biology, other than for medical or veterinary use; chemicals for use in the purification of proteins for in vitro use; chemicals for use in the purification of nucleic acids for in vitro use; chemical stabilizers for use on biological samples; chemical reagents for use in multiplying nucleic acid amounts, other than for medical and veterinary purposes; chemicals for use in performing nucleic acid polymerase chain reactions for use in industry, other than medical and veterinary purposes; enzymes in liquid form for industrial use; enzymes for industrial purposes, for labelling and for measuring proteins and protein fragments, other than medical purposes; kits, namely, testing kits containing nucleotides, polynucleotides, enzymes and buffer solutions for labelling and analysing biomolecules for laboratory or research use; kits for labelling and analysing biomolecules, consisting primarily of reagents for scientific purposes; chemicals for use in the purification of proteins, polypeptides and nucleic acids for in vitro use; diagnostic reagents for in-vitro use other than medical; diagnostic reagents for in-vitro use, other than for medical use, namely, enzymes, oligonucleotides and buffer solutions for scientific or research purposes for the enhancement, labelling and analysis of biopolymers and nucleic acids; diagnostic reagents for in-vitro use, in relation to biochemistry, clinical chemistry, molecular biology and microbiology; enzymes other than for medical use for labelling and measuring proteins and protein fractions; biomolecule labelling and analysis kits comprising reagents for use in scientific research; kits containing chemicals, reagents, enzymes and buffer solutions for industrial and scientific research use; kits for labelling and analysing biomolecules comprised primarily of biopolymers and nucleic acids for industrial and scientific research use; kits consisting primarily of chemicals, reagents, enzymes and buffer solutions used in analytical chemistry for research purposes; kits for labelling and analysing, namely, kits comprised primarily of unprocessed biopolymers and nucleic acids for laboratory use; nucleic acids for laboratory use; nucleic acids for scientific purposes; nucleic acid for use in nucleic acid amplification processes other than for medical use; nucleic acid sequencing preparations other than for medical use; nucleic acid chemical reagents for use in forensic analysis other than for medical purposes; reagents and unprocessed polymers, in each case for use in environmental analyses, for geophysical analyses and for food analyses, all for scientific use; chemical and biochemical reagents for microbiological analysis, other than for medical or veterinary purposes; nucleic acid amplification reagents for laboratory use; reagents for microbiological analysis other than for medical or veterinary purposes; nucleic acid amplification reagents other than for medical use; monoclonal antibodies for scientific purposes, other than for medical or veterinary use; chemicals, namely, monoclonal antibodies for industrial use; monoclonal antibodies for diagnostic use other than for medical purposes; tagged antibodies being biochemicals for laboratory use; antibody chemical reagents for scientific purposes; unprocessed polymers for use in the analysis of nucleic acids; proteins in raw material form for binding and detection of antibodies for scientific research, other than for medical use | ACTIVE | — |
| 005 | Medical and veterinary preparations, namely, enzyme preparations for medical purposes; biological tissue cultures for veterinary purposes; biological tissue cultures for medical purposes; biological skin, tissue intended for subsequent implantation; diagnostic chemical reagents for medical use; chemical preparations being chemical reagents for use in DNA analysis for medical purposes; diagnostic preparations and materials, namely, diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; in vitro diagnostic preparations for medical or veterinary purposes; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic reagents and assays for testing biological tissues; medical diagnostic reagents and assays for testing biological tissues, namely, living tissue and dead tissue; medical diagnostic reagents and assays for testing biological tissues, namely, living biopsy tissue and dead autopsy tissue; nucleic acid sequences for medical and veterinary purposes; radioactive preparations being radioactive substances for medical and veterinary diagnosis; reactants, namely, medical diagnostic reagents for medical and veterinary diagnosis; chemical and biochemical reagents for diagnostic tests for medical purposes; reagents for medical and veterinary diagnostic purposes; reagents for medical and veterinary diagnostic medicine tests; clinical diagnostic reagents for medical use; reagents for veterinary and medical purposes; reagents and media for use in diagnostic tests for medical or veterinary purposes; diagnostic biomarker reagents for use with analysers for medical and veterinary purposes. | ACTIVE | — |
| 009 | Scientific research and laboratory apparatus, namely, scientific apparatus and instruments for measuring relative DNA, RNA and protein, and structural and replacement parts and fittings therefor; Scientific research and laboratory apparatus, namely, capillary electrophoresis apparatus, not for medical purposes; teaching apparatus, namely, medical diagnostic simulators for use as teaching aids for analysis of DNA or RNA; scientific laboratory apparatus and instruments for extracting nucleic acid, DNA, RNA and proteins; scientific apparatus and instruments, namely, medical laboratory research instruments for detecting and DNA analysis; research apparatus and instruments, namely, electrophoresis apparatus not for medical purposes; capillary tubes for samples for laboratory use; capillary tubes for blood for laboratory use; solid phase extraction cartridges for laboratory use; laboratory apparatus and instruments, namely, hand-operated laboratory tools for manipulating laboratory samples; laboratory apparatus and instruments, namely, laboratory centrifuges for carrying out molecular biological measurements; laboratory instrument for the detection of pathogens and toxins in a biological sample for research use; devices, namely, nano-particle size analysers for analysing genome information; devices, namely, laboratory centrifuges for carrying out molecular biological measurements; research laboratory analysers for measuring, testing and analysing blood and other bodily fluids; nucleic acid sequencers for scientific purposes; quantitative polymerase chain reaction (PCR) instruments for scientific use, namely, medical laboratory research instruments for DNA analysis; DNA chips; DNA microarray; biochips for research or scientific purposes; bio-sensors being sensor chips for scientific use; bioreactors for laboratory use; laboratory chemical reactors; diagnostic apparatus for the detection of pathogens for laboratory or research use, not for medical purposes; disposable plastic bioreactors for biological samples for cell culturing; real-time polymerase chain reaction (PCR) instruments for scientific use, namely, medical laboratory research instruments for DNA analysis; electrophoresis apparatus, not for medical purposes; downloadable application software for document management; application software, namely, integrated software packages comprised of downloadable software for use in laboratory automation for integrating manufacturing machine operations, track problems and generate production reports; downloadable computer operating software for use in medical decision support systems; software for monitoring, analysing, controlling and running physical world operations, namely, downloadable bioinformatics operating software for monitoring, analysing, and controlling laboratory machines; downloadable optical mark recognition (OMR) software for recognizing marks made of paper form | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, medical apparatus and instruments for monitoring physiological condition, blood, blood components, blood properties, urine properties and cell properties and vital signs; diagnostic apparatus for medical purposes, namely apparatus for diagnostic and medical purposes used in medical laboratories for testing blood, cancer cells and biomarker; medical diagnostic, examination, and monitoring equipment, namely, medical diagnostic apparatus incorporating recorded operating system software for testing blood, blood properties, cancer cells, DNA and RNA and computerized medical recording and analysis apparatus for the diagnosis and treatment of cancer; body composition analysers for medical purposes; apparatus for DNA and RNA testing for medical purposes; genetic testing apparatus for medical purposes; electrophoresis apparatus for medical purposes; real-time polymerase chain reaction (pcr) instruments for medical use; quantitative polymerase chain reaction (pcr) instruments for medical use; immunological analysers, namely, medical devices for analysing and identifying biomarker. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Biotype GmbH
- Other trademarks owned by Biotype GmbH
- Other trademarks owned by Biotype GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named M
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 11, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 25, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 25, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 11, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 11, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 11, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 7, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 22, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 22, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 23, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 23, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 17, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 21, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 21, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 21, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 21, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 21, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 20, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 20, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 20, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 2, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 2, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 2, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 29, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 11, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 24, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 24, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 1, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 30, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 28, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 11, 2024 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| May 27, 2024 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Apr 21, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 27, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 23, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 22, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |